PRCT Similar Chart Price Prediction
The price of PRCT is predicted to go up -9.26%, based on the high correlation periods with CCM. The similarity of these two price pattern on the periods is 97.89%.
PRCT
CCM
Down: -9.26%Similarity: 97.89%
PRCT Revenue Forecast
PRCT EPS Forecast
PRCT FAQs
What is bull’s view on PRCT?
What is bear's view on PRCT?
What is PRCT revenue forecast for next quarter？
What is PRCT eps forecast for next quarter？
PRCT Analyst's Forecast
Nathan Treybeck
Wells Fargo
Buy
2024-12-03
Price Target
$112
Upside
+16.09%
Wells Fargo resumed coverage of Procept BioRobotics with an Overweight rating and $112 price target. The firm believes aquablation remains early stages in its adoption, which will be further supported by a new product cycle, the analyst tells investors in a research note. Procept is comfortable with 2025 consensus estimates, Wells says, adding that the firm is receiving "generally positive" physician feedback on Hydros.
Patrick Wood
Morgan Stanley
Buy
2024-12-02
Price Target
$105
Upside
+9.25%
Michael Sarcone
Jefferies
Hold
2024-11-14
Price Target
$95
Upside
+10.58%
